Abstract
Objective
To investigate whether leptin receptor (LEPR) 223A>G polymorphism influences serum lipid levels and whether this polymorphism affects the effectiveness of simvastatin in Chinese patients with coronary heart disease (CHD).
Methods
A total of 312 patients with CHD were treated with simvastatin 20 mg/day. Fasting serum lipids were determined before and after 12 weeks of treatment.
Results
Patients with AA genotype had significantly higher total cholesterol (TC) levels and lower high-density lipoprotein cholesterol (HDL-C) levels than those with GG genotype (P < 0.05) before simvastatin treatment. In addition, the ability of simvastatin to increase HDL-C levels was significantly lower in patients with AA genotype than those with GG genotype (P < 0.05).
Conclusions
The 223A>G polymorphism of LEPR significantly modulates the HDL-C response to simvastatin in Chinese patients with CHD.
Similar content being viewed by others
References
Wenger NK, Shaw LJ, Vaccarino V (2008) Coronary heart disease in women: update 2008. Clin Pharmacol Ther 83:37–51
Ades PA, Savage PD, Toth MJ, Schneider DJ, Audelin MC, Bunn JY, Ludlow M (2008) The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease. Int J Obes 32:967–974
Ahima RS, Lazar MA (2008) Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22:1023–1031
Bingham NC, Anderson KK, Reuter AL, Stallings NR, Parker KL (2008) Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology 149:2138–2148
Gulturk S, Cetin A, Erdal S (2008) Association of leptin with insulin resistance, body composition, and lipid parameters in postmenopausal women and men in type 2 diabetes mellitus. Saudi Med J 29:813–820
Nelson SM, Freeman DJ, Sattar N, Johnstone FD, Lindsay RS (2007) IGF-1 and leptin associate with fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes. Diabetes 56:2705–2709
Baratta R, Amato S, Degano C, Farina MG, Patane G, Vigneri R, Frittitta L (2004) Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 89:2665–2671
Dudakovic A, Wiemer AJ, Lamb KM, Vonnahme LA, Dietz SE, Hohl RJ (2008) Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes. J Pharmacol Exp Ther 324:1028–1036
Assmann G, Kannenberg F, Ramey DR, Musliner TA, Gutkin SW, Veltri EP (2008) Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia. Curr Med Res Opin 24:249–259
Myerson M, Ngai C, Jones J, Holleran S, Ramakrishnan R, Berglund L, Ginsberg HN (2005) Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia. J Lipid Res 46:2735–2744
Kajinami K, Takekoshi N, Brousseau ME, Schaefer EJ (2004) Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management. Atherosclerosis 177:219–234
Popko K, Gorska E, Wasik M, Stoklosa A, Plywaczewski R, Winiarska M, Gorecka D, Sliwinski P, Demkow U (2007) Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients. J Physiol Pharmacol 58:551–561
Van der Vleuten GM, Kluijtmans LA, Hijmans A, Blom HJ, Stalenhoef AF, de Graaf J (2006) The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia. Int J Obes 30:892–898
Arca M (2007) Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome. Drugs 67:43–54
Keating GM, Robinson DM (2008) Rosuvastatin: a review of its effect on atherosclerosis. Am J Cardiovasc Drugs 8:127–146
Tachibana-Iimori R, Tabara Y, Kusuhara H, Kohara K, Kawamoto R, Nakura J, Tokunaga K, Kondo I, Sugiyama Y, Miki T (2004) Effect of genetic polymorphism of OATP-C(SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors. Drug Metab Pharmacokinet 19:375–380
Morton NM, Emilsson V, de Groot P, Pallett AL, Cawthorne MA (1999) Leptin signalling in pancreatic islets and clonal insulin-secreting cells. J Mol Endocrinol 22:173–184
Stefan N, Vozarova B, Del Parigi A, Ossowski V, Thompson DB, Hanson RL, Ravussin E, Tataranni PA (2002) The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int J Obesity Relat Metab Disord 26:1629–1632
Coenen KR, Gruen ML, Hasty AH (2007) Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice. J Nutr Biochem 18:727–735
Begriche K, Letteron P, Abbey-Toby A, Vadrot N, Robin MA, Bado A, Pessayre D, Fromenty B (2008) Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice. Am J Physiol Endocrinol Metab 294:E939–E951
Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430
Jiao S, Matsuzawa Y, Matsubara K, Kubo M, Tokunaga K, Odaka H, Ikeda H, Matsuo T, Tarui S (1991) Abnormalities of plasma lipoproteins in a new genetically obese rat with non-insulin-dependent diabetes mellitus (Wistar fatty rat). Int J Obesity 15:487–495
VanPatten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE (2001) Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol 281:G393–404
Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339–343
Mendez-Sanchez N, Gonzalez V, King-Martinez AC, Sanchez H, Uribe M (2002) Plasma leptin and the cholesterol saturation of bile are correlated in obese women after weight loss. J Nutr 132:2195–2198
Wu ZH, Zhao SP, Ye HJ (2006) The beneficial effects of high-density lipoprotein on adipocytes may relate to its anti-atherogenic properties. Med Hypotheses 67:1195–1199
Soro A, Jauhiainen M, Ehnholm C, Taskinen MR (2003) Determinants of low HDL levels in familial combined hyperlipidemia. J Lipid Res 44:1536–1544
Quinton ND, Lee AJ, Ross RJ, Eastell R, Blakemore AI (2001) A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet 108:233–236
Kullo IJ, Turner ST, Boerwinkle E, Kardia SL, de Andrade AM (2005) A novel quantitative trait locus on chromosome 1 with pleiotropic effects on HDL-cholesterol and LDL particle size in hypertensive sibships. Am J Hypertens 18:1084–1090
Author information
Authors and Affiliations
Corresponding author
Additional information
Yan-Ming Sun and Jia Li contributed equally to this study.
Rights and permissions
About this article
Cite this article
Sun, YM., Wang, LF., Li, J. et al. The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease. Eur J Clin Pharmacol 65, 157–161 (2009). https://doi.org/10.1007/s00228-008-0578-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-008-0578-3